Fracture risk prediction, treatment thresholds, and the role of bone mineral density: a comparative analysis of FRAX and SHAFRE [0.03%]
骨折风险预测、治疗门槛及骨密度的作用：FRAX和SHAFRE的比较分析
Anna Nordström,Marcel Ballin,Viktor Ahlqvist et al.
Anna Nordström et al.
Introduction: Accurate prediction of fracture risk is important for treatment decisions, yet evaluations of commonly used thresholds are limited, and the added value of volumetric bone mineral density (vBMD) remains uncer...
Comment on "One‑year bone mineral density gains with anti‑osteoporotic medications and clinical factors associated with non‑BMD gainers" [0.03%]
关于“抗骨质疏松药物一年骨矿物质密度获益及非骨矿物质密度受益相关临床因素”的评论
Jie Xiao,XiaoTian Li,Jiaqi Huang
Jie Xiao
Bone fragility and atypical femoral fractures in SLE: role of disease activity, infection, and treatment [0.03%]
系统性红斑狼疮患者的骨质疏松与股骨不典型骨折：疾病活动、感染和治疗的作用
Hiroe Sato,Naoki Kondo,Tomoya Watarai et al.
Hiroe Sato et al.
Introduction: To determine the incidence and risk factors of fragility fractures and atypical femoral fracture (AFF)-related events in patients with systemic lupus erythematosus (SLE) receiving long-term glucocorticoid (G...
Bone mineral density after spinal cord injury: assessment of hip and knee measurements-response to the Letter to Editor [0.03%]
脊髓损伤后的骨密度变化：髋关节和膝关节测量的评估——对《致编辑信》的回复
Nurdan Korkmaz,Gökhan Yardımcı,Ayşe Naz Kalem Özgen et al.
Nurdan Korkmaz et al.
Response to letter to the editor on "Preoperative treatment and postoperative outcomes in osteoporotic patients with vertebral fractures: a longitudinal database study" [0.03%]
论著《骨质疏松症椎体骨折患者的术前治疗和术后结局——一项纵向数据库研究》的回复
Ruriko Koto,Shiori Yoshida,Akihiro Nakajima et al.
Ruriko Koto et al.
Neuroimmune interactions in arthritis: linking pain sensitisation and inflammation [0.03%]
风湿病中的神经免疫相互作用：连接疼痛过敏和炎症
Tammie Tao Min Sow,Tetsuo Hasegawa
Tammie Tao Min Sow
Arthritis represents a group of chronic joint diseases characterised by persistent inflammation, pain, and progressive tissue damage. Despite advances in therapeutic management, many patients experience incomplete symptom relief, highlighti...
Pain after osteoporotic fractures using mouse models and patient samples [0.03%]
基于小鼠模型和患者样本的骨质疏松性骨折后疼痛研究
A Radulescu,M Hopkinson,Y Chang et al.
A Radulescu et al.
Introduction: Osteoporosis can cause chronic pain, but the mechanisms are unclear. This study investigates pain behaviours in mouse models of osteoporosis and fracture together with nociceptive markers expression in bone ...
DC-STAMP and OC-STAMP cooperatively regulate osteoclast and foreign body giant cell cell-cell fusion [0.03%]
DC-STAMP和OC-STAMP协同调节破骨细胞和异物巨噬细胞的融合
Fuka Homma,Ryotaro Iwasaki,Makoto Tateyama et al.
Fuka Homma et al.
Introduction: Osteoclasts and foreign body giant cells (FBGCs) are multi-nuclear cells established by fusion of their mono-nuclear forms. Multi-nucleation via cell-cell fusion is a common characteristic of osteoclasts and...
Trupti Nagendra Prasad,L Romesh Sharma,Anil Bhansali et al.
Trupti Nagendra Prasad et al.
Background: A significant proportion of bone loss per year occurs starting around 1-3 years before menopause. A number of fractures occur in the osteopenic range of bone mineral density (BMD). There are no recommendations...
Long-term association between body size in adolescence or early adulthood and future fracture risk [0.03%]
青春期或成年早期体格大小与未来骨折风险的长期关系
Makoto Sunayama,Naomi Omi,Takeshi Nishiyama et al.
Makoto Sunayama et al.
Introduction: Body size is known to influence bone mass and fracture risk throughout life; however, the critical period at which body size most strongly affects later fracture risk remains unclear. Herein, we investigated...